definiens: shall mean any product sold in combination ( in th e same package, including as a co - formulation, or otherwise sold together for a singl e price ) containing as active ingredients both ( A ) Royalty Product(s ) and ( B ) one or more other pharmaceutical ly active compounds or substances . In the event tha t such Royalty Product - 16 - is not sold separately, Sales and Net Sales for mil estone and royalty calculations shall be determined based on an apportionment to reflect the Parties ’ agreed upon r easonable good faith estimate of the fair market va lue of such Royalty Product and the one or more other active in gredients in such Combination Product, as mutually agreed in good faith by the Parties ( and, if the Parties d o not reach an agreement on such apportionment, the Dispute shall be resolved in accordance with the dispute re solution provisions in Article 14 )